Foamy Virus Vectors for HIV Gene Therapy
Highly active antiretroviral therapy (HAART) has vastly improved outcomes for patients infected with HIV, yet it is a lifelong regimen that is expensive and has significant side effects. Retroviral gene therapy is a promising alternative treatment for HIV/AIDS; however, inefficient gene delivery to...
Main Authors: | Grant D. Trobridge, Miles E. Olszko |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2013-10-01
|
Series: | Viruses |
Subjects: | |
Online Access: | http://www.mdpi.com/1999-4915/5/10/2585 |
Similar Items
-
Prospects for Foamy Viral Vector Anti-HIV Gene Therapy
by: Arun K. Nalla, et al.
Published: (2016-03-01) -
Large Animal Models for Foamy Virus Vector Gene Therapy
by: Peter A. Horn, et al.
Published: (2012-12-01) -
The First Co-Opted Endogenous Foamy Viruses and the Evolutionary History of Reptilian Foamy Viruses
by: Pakorn Aiewsakun, et al.
Published: (2019-07-01) -
Foamy virus zoonotic infections
by: Delia M. Pinto-Santini, et al.
Published: (2017-12-01) -
Feline Foamy Virus-Based Vectors: Advantages of an Authentic Animal Model
by: Martin Löchelt, et al.
Published: (2013-07-01)